 Aurinia Pharmaceuticals Inc. NASDAQ:AUPH Q2 2022 Earnings Conference Call August 4, 2022 8:30 AM ET Company Participants DeDe Sheel Vice President-Investor Relations Peter Greenleaf President and Chief Executive Officer Joe Miller Chief Financial Officer Neil Solomons Chief Medical Officer Conference Call Participants Ed Arce HC Wainwright Justin Kim Oppenheimer Olivia Brayer Cantor Fitzgerald Sahil Dhingra RBC Operator Greetings, and welcome to Aurinia Pharmaceuticals Second Quarter 2022 Financial and Operational Results Conference Call. At this time all participants are in listen-only mode. 